Qinghua Feng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Qinghua Feng has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Nancy B. Kiviat
Pathology, University of Washington, Seattle, WA, USA.
2 shared publications - Ann Elizabeth Kurth
Yale University School of Nursing, Orange, Connecticut
1 shared publication - Diane P. Martin
From the *Emerging Disease Surveillance and Response Unit, Division of Health Security and Emergencies, World Health Organization Regional Office for the Western Pacific, Manila, Philippines; †Research Group, Department of Epidemiology, University of Washington, Seattle, WA; ‡College of Nursing and Director, Global Health Initiatives, New York University, New York, NY; Departments of §Health Services, ¶Biostatistics, ‖Pathology, Harborview Medical Center, University of Washington, Seattle, WA
1 shared publication - Hona Jang
University of Washington, 1959 NE Pacific St., Seattle, WA, 98195, USA.
1 shared publication - James P. Hughes
Department of Biostatistics, University of Washington, Seattle, WA, USA
1 shared publication - Juliet Dang
CSL Seqirus, North Bend, OR 97459, USA
1 shared publication
Latest Publications
- Open Access
- 15 October 2015
- Published by Springer Nature in BMC Oral Health
- Vol. 15 (1) , 126
Detection of HPV in oral rinse samples from OPSCC and non-OPSCC patients
Due to the increasing rates of oropharyngeal cancer, oral HPV infection is a significant concern. Methods for detecting oral HPVs is not standardized as there are different techniques available. We propose that use of oral rinse samples to detect for HPVs is a suitable technique within a clinic setting. Thus, our main objective is to study HPV detection in oral rinse samples. In our study, we used oral rinse sample collection coupled with real-time PCR to detect for HPVs types 16 and 18, and preferentially amplified FAP PCR samples to detect for a broad range of HPVs, in oropharyngeal squamous cell carcinoma (OPSCC), non-OPSCC, and healthy patients. Thirty three percent of 100 cancer patients were positive for any type of HPV; of those 23 were positive for HPV16. Only 1 of 110 healthy controls was positive (this subject was positive for HPV18). Our results indicate that HPV detection in oral rinse samples may be useful as a screening tool to detect HPV-associated oral cancers.
- 15 October 2015
- Published by Springer Nature in BMC Oral Health
- Vol. 15 (1) , 126
Open AccessDetection of HPV in oral rinse samples from OPSCC and non-OPSCC patients
Due to the increasing rates of oropharyngeal cancer, oral HPV infection is a significant concern. Methods for detecting oral HPVs is not standardized as there are different techniques available. We propose that use of oral rinse samples to detect for HPVs is a suitable technique within a clinic setting. Thus, our main objective is to study HPV detection in oral rinse samples. In our study, we used oral rinse sample collection coupled with real-time PCR to detect for HPVs types 16 and 18, and preferentially amplified FAP PCR samples to detect for a broad range of HPVs, in oropharyngeal squamous cell carcinoma (OPSCC), non-OPSCC, and healthy patients. Thirty three percent of 100 cancer patients were positive for any type of HPV; of those 23 were positive for HPV16. Only 1 of 110 healthy controls was positive (this subject was positive for HPV18). Our results indicate that HPV detection in oral rinse samples may be useful as a screening tool to detect HPV-associated oral cancers.
- 1 August 2012
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 39 (8) , 583-587
Disclosure of Genital Human Papillomavirus Infection to Female Sex Partners by Young Men
A survey was administered to male university students who tested positive for high-risk human papillomavirus. Disclosure was more likely in men with fewer partners, in main partnerships, and in longer partnerships. Disclosure was associated with discussing the Pap test/human papillomavirus vaccine with female partners and not associated with a worsening relationship.
- 1 August 2012
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 39 (8) , 583-587
Disclosure of Genital Human Papillomavirus Infection to Female Sex Partners by Young Men
A survey was administered to male university students who tested positive for high-risk human papillomavirus. Disclosure was more likely in men with fewer partners, in main partnerships, and in longer partnerships. Disclosure was associated with discussing the Pap test/human papillomavirus vaccine with female partners and not associated with a worsening relationship.
- 14 June 2012
- Published by Springer Nature
- Vol. 903, 205-223
Protocol for the Detection and Genotyping of Human Papillomaviruses Using a Liquid Bead Microarray Assay
More than 100 human papillomavirus (HPV) types have been identified, and over 40 of them infect the anogenital epithelium. Because each HPV type is associated with different risks for the development of cervical cancer, detecting and genotyping HPVs has increasingly become an integral part of cervical cancer control. Here, we describe a Luminex assay-based liquid bead microarray assay for genotyping 37 HPV types, which is objective, scalable, amenable to a high-throughput configuration, and has the potential to be automated.
- 14 June 2012
- Published by Springer Nature
- Vol. 903, 205-223
Protocol for the Detection and Genotyping of Human Papillomaviruses Using a Liquid Bead Microarray Assay
More than 100 human papillomavirus (HPV) types have been identified, and over 40 of them infect the anogenital epithelium. Because each HPV type is associated with different risks for the development of cervical cancer, detecting and genotyping HPVs has increasingly become an integral part of cervical cancer control. Here, we describe a Luminex assay-based liquid bead microarray assay for genotyping 37 HPV types, which is objective, scalable, amenable to a high-throughput configuration, and has the potential to be automated.